vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Uniti Group Inc. (UNIT). Click either name above to swap in a different company.

Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $722.6M, roughly 1.3× Uniti Group Inc.). Uniti Group Inc. runs the higher net margin — 222.7% vs 0.7%, a 222.0% gap on every dollar of revenue.

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

Uniti was an electric vehicle prototype by Uniti Sweden, a Swedish automotive startup. The company was founded in January 2016 by a team of students and engineers under CEO Lewis Horne which aimed at developing an electric microcar in Lund, Sweden. It filed for bankruptcy in April 2022. No products were ever delivered to customers.

ASTH vs UNIT — Head-to-Head

Bigger by revenue
ASTH
ASTH
1.3× larger
ASTH
$950.5M
$722.6M
UNIT
Higher net margin
UNIT
UNIT
222.0% more per $
UNIT
222.7%
0.7%
ASTH

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ASTH
ASTH
UNIT
UNIT
Revenue
$950.5M
$722.6M
Net Profit
$6.6M
$1.6B
Gross Margin
Operating Margin
1.9%
-5.9%
Net Margin
0.7%
222.7%
Revenue YoY
42.9%
Net Profit YoY
184.4%
EPS (diluted)
$0.12
$4.92

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
UNIT
UNIT
Q4 25
$950.5M
Q3 25
$956.0M
$722.6M
Q2 25
$654.8M
Q1 25
$620.4M
Q4 24
$665.2M
Q3 24
$478.7M
Q2 24
$486.3M
Q1 24
$404.4M
Net Profit
ASTH
ASTH
UNIT
UNIT
Q4 25
$6.6M
Q3 25
$373.0K
$1.6B
Q2 25
$9.4M
Q1 25
$6.7M
Q4 24
$-7.8M
Q3 24
$16.1M
Q2 24
$19.2M
Q1 24
$14.8M
Operating Margin
ASTH
ASTH
UNIT
UNIT
Q4 25
1.9%
Q3 25
2.0%
-5.9%
Q2 25
3.1%
Q1 25
3.3%
Q4 24
0.1%
Q3 24
5.9%
Q2 24
6.2%
Q1 24
7.5%
Net Margin
ASTH
ASTH
UNIT
UNIT
Q4 25
0.7%
Q3 25
0.0%
222.7%
Q2 25
1.4%
Q1 25
1.1%
Q4 24
-1.2%
Q3 24
3.4%
Q2 24
3.9%
Q1 24
3.7%
EPS (diluted)
ASTH
ASTH
UNIT
UNIT
Q4 25
$0.12
Q3 25
$0.01
$4.92
Q2 25
$0.19
Q1 25
$0.14
Q4 24
$-0.14
Q3 24
$0.33
Q2 24
$0.40
Q1 24
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
UNIT
UNIT
Cash + ST InvestmentsLiquidity on hand
$429.5M
$158.0M
Total DebtLower is stronger
$9.3B
Stockholders' EquityBook value
$779.3M
$680.7M
Total Assets
$2.2B
$12.1B
Debt / EquityLower = less leverage
13.64×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
UNIT
UNIT
Q4 25
$429.5M
Q3 25
$463.4M
$158.0M
Q2 25
$342.1M
Q1 25
$260.9M
Q4 24
$290.8M
Q3 24
$350.3M
Q2 24
$327.7M
Q1 24
$337.3M
Total Debt
ASTH
ASTH
UNIT
UNIT
Q4 25
Q3 25
$9.3B
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ASTH
ASTH
UNIT
UNIT
Q4 25
$779.3M
Q3 25
$775.5M
$680.7M
Q2 25
$765.5M
Q1 25
$745.4M
Q4 24
$712.7M
Q3 24
$704.6M
Q2 24
$678.9M
Q1 24
$653.5M
Total Assets
ASTH
ASTH
UNIT
UNIT
Q4 25
$2.2B
Q3 25
$2.2B
$12.1B
Q2 25
$1.4B
Q1 25
$1.3B
Q4 24
$1.4B
Q3 24
$1.3B
Q2 24
$1.3B
Q1 24
$1.2B
Debt / Equity
ASTH
ASTH
UNIT
UNIT
Q4 25
Q3 25
13.64×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
UNIT
UNIT
Operating Cash FlowLast quarter
$-2.9M
$229.8M
Free Cash FlowOCF − Capex
$-6.0M
FCF MarginFCF / Revenue
-0.6%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
-0.44×
0.14×
TTM Free Cash FlowTrailing 4 quarters
$104.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
UNIT
UNIT
Q4 25
$-2.9M
Q3 25
$10.0M
$229.8M
Q2 25
$90.9M
Q1 25
$16.6M
Q4 24
$-10.9M
Q3 24
$34.0M
Q2 24
$23.2M
Q1 24
$6.0M
Free Cash Flow
ASTH
ASTH
UNIT
UNIT
Q4 25
$-6.0M
Q3 25
$7.4M
Q2 25
$89.5M
Q1 25
$13.6M
Q4 24
$-13.5M
Q3 24
$31.7M
Q2 24
$20.4M
Q1 24
$5.6M
FCF Margin
ASTH
ASTH
UNIT
UNIT
Q4 25
-0.6%
Q3 25
0.8%
Q2 25
13.7%
Q1 25
2.2%
Q4 24
-2.0%
Q3 24
6.6%
Q2 24
4.2%
Q1 24
1.4%
Capex Intensity
ASTH
ASTH
UNIT
UNIT
Q4 25
0.3%
Q3 25
0.3%
Q2 25
0.2%
Q1 25
0.5%
Q4 24
0.4%
Q3 24
0.5%
Q2 24
0.6%
Q1 24
0.1%
Cash Conversion
ASTH
ASTH
UNIT
UNIT
Q4 25
-0.44×
Q3 25
26.69×
0.14×
Q2 25
9.65×
Q1 25
2.48×
Q4 24
Q3 24
2.11×
Q2 24
1.21×
Q1 24
0.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

UNIT
UNIT

Revenue And Sales$315.5M44%
DSL Subscriber And Other$102.7M14%
Fiber Subscriber$77.7M11%
Business Services$66.4M9%
Uniti Fiber$55.7M8%
Wholesale$54.8M8%
Sales Revenue$27.3M4%
Time Division Multiplexing$8.7M1%
Switched Access$2.2M0%

Related Comparisons